{"disease":{"id":"alpha-1-antitrypsin-deficiency-aatd","name":"alpha 1 antitrypsin deficiency aatd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07152834","title":"Screening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction","phase":"","overall_status":"RECRUITING","enrollment_count":734,"lead_sponsor_name":"Muğla Sıtkı Koçman University","has_results":false},{"nct_id":"NCT01851642","title":"Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs","phase":"","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"University of Florida","has_results":false},{"nct_id":"NCT03679598","title":"Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":true},{"nct_id":"NCT07242079","title":"Effect Of Pulmonary Rehabilitation in Patients With Alpha-1 Antitrypsin Deficiency","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University of Parma","has_results":false},{"nct_id":"NCT06186492","title":"A Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Wave Life Sciences Ltd.","has_results":true},{"nct_id":"NCT03815396","title":"Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Inhibrx Biosciences, Inc","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}